Enrofloxacin/BSA

• Background:

  It is a bactericidal agent. The bactericidal activity of enrofloxacin is concentration-dependent, with susceptible bacteria cell death occurring within 20–30 minutes of exposure. Enrofloxacin has demonstrated a significant post-antibiotic effect for both Gram-negative and Gram-positive bacteria and is active in both stationary and growth phases of bacterial replication. Enrofloxacin is partially deethylated by CYP450 into the active metabolite ciprofloxacin, which is also a fluoroquinolone antibiotic, used preferentially in humans.

• Expression System:

  Native protein

• Conjugation:

  Unconjugated

• Tag:

  No tag

• Source:

  Small molecule-conjugated carrier protein

• Applications:

  Others

• Endotoxin:

  Not Tested

• Purity:

  >95% by SDS-PAGE

• Buffer:

  0.01M PBS (pH7.4)

• Storage Conditions:

  Store at -70°C or -20°C. Avoid repeated freeze/thaw cycles.